Home Health & Medicine Pharmaceutical Intermediate

99% High Purity Pharmaceutical Chemical Powder Edoxaban CAS 480449-70-5

Product Details

Customization:	Available
Powder:	Yes
Customized:	Customized

Still deciding? Get samples of US$ 450/Bag

Request Sample

Xi'an Frazer Biotech Co., Ltd.

Manufacturer/Factory

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters

The supplier has import and export rights

High Repeat Buyers Choice

More than 50% of buyers repeatedly choose the supplier

Experienced Team

The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience

Patents Awarded

The supplier had awarded 1 patents, you can check the Audit Report for more information

to see all verified strength labels (11)

99% High Purity Pharmaceutical Chemical Powder Edoxaban CAS 480449-70-5 pictures & photos

Add Inquiry Basket to Compare

Find Similar Products

Product Description

Company Info.

Basic Info.

Model NO.

Frazer-Edoxaban

Certification

GMP, HSE, ISO 9001, USP, BP

Suitable for

Elderly, Children, Adult

State

White Powder

Purity

>99%

Appearance

White Powder

CAS No

134678-17-4

Shelf Life

2 Years

Test Method

HPLC

Storage

Store Cool Dry Place

Resource

Natural

Quality Requirement

Strictly Quality Control

Transport Package

Foil Bag

Specification

99%

Trademark

Xi′an Frazer Biotech Co., Ltd.

Origin

China

Production Capacity

1000kg/Month

Product Description

99% High Purity Pharmaceutical Chemical Powder Edoxaban CAS 480449-70-5

Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban (tosylate Monohydrate) was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. Edoxaban (tosylate Monohydrate) was also approved by the FDA in January 2015 for the prevention of stroke and non-central-nervous-system systemic embolism.